ARTICLE | Clinical News
Leucotropin: Completed Phase III trial enrollment
April 2, 2001 7:00 AM UTC
Cangene Corp. (TSE:CNJ), Mississauga, Ontario Product: Leucotropin Business: Cancer Therapeutic category: Stem cell stimulation Target: Hematopoietic stem cells Description: Granulocyte macrophage-co...